On Air Now On with Mario Lopez
Listen Live

FDA approves new drug to protect infants, toddlers from RSV

WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.

RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.

The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.

The full article is available at ozarksfirst.com.

More from Local News

Listen Live to Our Family of Stations

     

Ways To Listen

Upcoming Show Schedules